Online, which included ER status and grade as primary tumour characteristics, was routinely used at the start of the century, newer tools like PREDICT Breast 2.0 incorporate and weigh HER2 status and Ki67 expression, yielding a more refined prognostication in breast cancer patients [13,14]. This evidence concerns the gene ERBB2 and breast cancer.